3,4,5,6-tetrahydrouridine;nsc-112907;nsc-112907-d;tetrahydro-4-hydroxy-1-beta-d-ribofuranosyl-2(1h)-pyrimidinon;TETRAHYDROURIDINE;3,4,5,6-Tetrahydrouridine (>80% by HPLC);Uridine, 3,4,5,6-tetrahydro-;(4S)-3,4,5,6-Tetrahydro-4β-hydroxy-1-(β-D-ribofuranosyl)pyrimidin-2(1H)-one
Tetrahydrouridine (THU) is a potent and specific inhibitor of cytidine deaminase (CDA), competitively blocking the enzyme's active site; it suppresses deamination in the catabolism of cytotoxic deoxycytidine analogues such as cytarabine (ara-C) and gemcitabine; THU enhances the anti-neoplastic efficacy of gemcitabine in certain pancreatic and lung carcinoma cell lines, regardless of their CDA expression levels; it sensitizes cancer cells to gemcitabine-induced cell death and induces S-phase arrest without triggering apoptosis.